The pharmacokinetics and pharmacodynamics of desmopressin: effect on plasma factor VIII:C and von Willebrand factor

Am J Ther. 1997 Jan;4(1):3-8. doi: 10.1097/00045391-199701000-00002.

Abstract

The relationship between plasma concentrations of desmopressin and clotting factors Factor VIII:C (FVIII:C) and von Willebrand Factor (vWF) were explored after a single 15-minute intravenous infusion of desmopressin (0.3 microg/kg) to 28 healthy male subjects. Individual plasma desmopressin-vWF and desmopressin-FVIII:C concentration/response-time data were fitted to a pharmacodynamic sigmoid E ( max ) model linked to a two-compartment open pharmacokinetic model (Ke0 link). The model demonstrated that the onset rate of pharmacodynamic activity for FVIII:C and vWF was relatively rapid following intravenous administration. However, the offset rate of pharmacodynamic activity was rate-limited by the elimination rate of desmopressin. Mean maximum pharmacodynamic activity for both factors was estimated to be three- to four-times higher than baseline activity, and the mean desmopressin concentrations that produce half-maximal effects were approximately 250 to 300 pg/mL. Interindividual variation in pharmacodynamic-parameter estimates were of the magnitude that suggests a wide range of pharmacodynamic responses are possible for a fixed desmopressin dose.

Publication types

  • Clinical Trial

MeSH terms

  • Adolescent
  • Adult
  • Algorithms
  • Deamino Arginine Vasopressin / blood
  • Deamino Arginine Vasopressin / pharmacokinetics*
  • Deamino Arginine Vasopressin / pharmacology*
  • Factor VIII / metabolism*
  • Humans
  • Hypoglycemic Agents / blood
  • Hypoglycemic Agents / pharmacokinetics*
  • Hypoglycemic Agents / pharmacology*
  • Infusions, Intravenous
  • Male
  • Middle Aged
  • Nonlinear Dynamics
  • von Willebrand Factor / metabolism*

Substances

  • Hypoglycemic Agents
  • von Willebrand Factor
  • Factor VIII
  • Deamino Arginine Vasopressin